Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors Secondary to Hyperkalemia Translates into Higher Cardiorenal Outcomes

INTRODUCTION: Discontinuation of renin-angiotensin-aldosterone system inhibitor (RAASi) is common after hyperkalemia. We evaluated the risk of kidney and mortality outcomes associated with RAASi discontinuation among patients with chronic kidney disease (CKD) and hyperkalemia. METHODS: We identified...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Jaejin, Zhou, Hui, Ni, Liang, Harrison, Teresa N., Wei, Rong, Agiro, Abiy, Brahmbhatt, Yasmin G., Oluwatosin, Yemmie, Schilling, Craig G., Sim, John J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Patient-Oriented, Translational Research: Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623389/
https://www.ncbi.nlm.nih.gov/pubmed/37231821
http://dx.doi.org/10.1159/000531102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623389/
https://www.ncbi.nlm.nih.gov/pubmed/37231821
http://dx.doi.org/10.1159/000531102

Ejemplares similares